GlaxoSmithKline Announces FDA Approval And The Launch Of Avandamet(R) (Rosiglitazone Maleate And Metformin HCl) In The Treatment Of Diabetes

... GlaxoSmithKline announced todayFDA approval of Avandamet(R) (rosiglitazone maleate and metformin HCl) foruse as initial treatment of type 2 diabetes as an adjunct to diet andexercise. Avandamet was previously approved as a second-line therapy -- itwas indicated for use in patients who were uncontrolled on metforminmonotherapy. [click link for full article] ...